Preterm Infant, Respiratory Distress Syndrome
Conditions
Keywords
preterm infant, respiratory distress syndrome, nasal high frequence oscillation ventilation
Brief summary
In very preterm infants with severe respiratory distress syndrome(RDS), invasive ventilation(IV) , besides nasal continuous positive airway pressure (NCPAP) and early/selective pulmonary surfactant administration, is one key cornerstone to reduce neonatal mortality. However, IV is related to increased risks of bronchopulmonary dysplasia (BPD) and abnormal developmental outcomes in the survival.Weaning from IV is therefore a key procedure to reducing these risks above, and if extubation does not success, repeated intubation and/or prolonged duration of IV will result in increased medical burden and intubation-associated complications and death. How to minimize the need for endotracheal ventilation and subsequent complications constitutes a challenge for neonatologists.
Detailed description
Early weaning from invasive ventilation and avoiding re-intubation remains a focus. Nowadays, early use of noninvasive respiratory support strategies has been suggested to be the most effective pathway to reduce those risks. NCPAP is a widely used way of noninvasive ventilation strategies in preterm infants. However, there is only 60% success rate in avoiding intubation. Supplying with the combined advantages of HFOV and NCPAP with high CO2 removal, no need for synchronisation, less volume/barotraumas, non-invasion and increased functional residual capacity, nasal high frequency oscillation ventilation (NHFOV) is considered as a strengthened version of NCPAP. Thus, NHFOV may be more effective as post-extubation respiratory support to avoid re-intubation and subsequent complications/sequelae comparing with NCPAP in preterm infants. To date, NHFOV was used increasingly in neonatal intensive care unit (NICU) around the world due to its convenient operation and no consideration of synchronisation, and several small studies have reported the beneficial effects of NHFOV in preterm infants. However, there were rare randomized controlled studies compared NHFOV with NCPAP as post-extubation respiratory support strategies in preterm infants. The purpose of the present study was to compare NHFOV with NCPAP as post-extubation respiratory support on the need for endotracheal ventilation and subsequent complications in preterm infants.
Interventions
DEVICENHFOV
NHFOV is used as the noninvasive mode after extubation
DEVICENCPAP
NCPAP is used as the noninvasive mode after extubation
Sponsors
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
30 Minutes to 1 Months
Healthy volunteers
No
Inclusion criteria
* The gestational age was less than 37 weeks; * These neonates were diagnosed with RDS and supported by invasive ventilation with synchronized intermittent mandatory ventilation (SIMV. The diagnosis of RDS was based on clinical manifestations and chest X-ray findings. The clinical signs and symptoms of RDS were respiratory distress, tachypnea, nasal flaring, groan, and cyanosis after birth. The typical X-ray picture of RDS showed a grain shadow, air bronchogram or white lung; * The neonates were ready to be extubated for the first time and subsequent noninvasive ventilation.
Exclusion criteria
* parents' decision not to participate; * major congenital anomalies; * died or left the NICU within 24 hour. Eligibility criteria for extubation: Besides the improved symptoms, X-rays and sufficient spontaneous breathing efforts, the eligibility criteria for extubation were peak inspiratory pressure (PIP) of 15-20 cm H2O, positive end expiratory pressure (PEEP) of 4-6 cm H2O, respiratory rate of 15 to 30, FiO2 from 0.21 to 0.30, hematocrit more than 35%. and arterialized capillary blood gas analysis need to meet the following criteria: pH\>7.20, PaCO2\<=55 mmHg.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| intubation rate | 3 days | the baby was re-intubated due to respiratory failure |
| total time of hospitalization | 100 days | the duration of baby in hospital |
| bronchopulmonary dysplasia(BPD) | at 28 days after birth or 36 weeks'gestational age or at discharge | bronchopulmonary dysplasia was diagnosed after extubation BPD was defined according to the National Institutes of Health consensus definition |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Intraventricular hemorrhage | 3 days | Intraventricular hemorrhage was diagnosed after extubation |
| airleaks | 3 days | airleaks was diagnosed after extubation |
| patent ductus arteriosus (PDA) | 100 days | patent ductus arteriosus (PDA) was diagnosed |
| mortality rate | 100 days | the baby died in hospital |
| Retinopathy of prematurity | 100 days | Retinopathy of prematurity was diagnosed after extubation |
| Neonatal necrotizing enterocolitis | 3 days | Neonatal necrotizing enterocolitis was diagnosed after extubation |
Countries
China
Outcome results
None listed